Vimarsana
Biggest News Aggregation in the World

Medtech Forum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medtech Forum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medtech Forum Today - Breaking & Trending Today

They stayed at an 'absolute gem' of a Dublin hotel. Now these councillors face questions - Vimarsana News

They stayed at an 'absolute gem' of a Dublin hotel. Now these councillors face questions

Hundreds of receipts obtained by Global News show how two councillors and three staff from the City of Brampton spent thousands on flights and hotels during a trip to Ireland.

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results - Alpha Teknova (NASDAQ:TKNO) - Vimarsana News

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results - Alpha Teknova (NASDAQ:TKNO)

Full year 2023 total revenue was $36.7 million, down 11% year-over-yearAchieved 36% annual growth in the number of Clinical Solutions customers in 2023Company provides 2024 revenue guidance of $35-38 million HOLLISTER,

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results

Full year 2023 total revenue was $36.7 million, down 11% year-over-year

908 Devices to Participate in Upcoming Investor Conferences - Vimarsana News

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. , a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. Cowen...

Schrödinger to Participate in Upcoming Investor Conferences - Vimarsana News

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the following...